{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:13:01Z","timestamp":1760141581949,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejso.2021.05.022","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T12:10:47Z","timestamp":1621426247000},"page":"2933-2938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of \u201ccritical lesions\u201d on outcomes following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3598-2035","authenticated-orcid":false,"given":"A.","family":"Ben-Yaacov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-453X","authenticated-orcid":false,"given":"S.","family":"Laks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Goldenshluger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nevo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Schtrechman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Margalit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Boursi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Shacham-Shmueli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8926-4154","authenticated-orcid":false,"given":"N.","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Purim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hazzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7972-9424","authenticated-orcid":false,"given":"L.","family":"Segev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Adileh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nissan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"35","key":"10.1016\/j.ejso.2021.05.022_bib1","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1200\/JCO.2008.17.7147","article-title":"Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741","volume":"26","author":"Sanoff","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.05.022_bib2","first-page":"97","article-title":"Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis","volume":"10","author":"Renouf","year":"2011","journal-title":"Clin Colorectal Canc"},{"issue":"6","key":"10.1016\/j.ejso.2021.05.022_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamaoncol.2015.1790","article-title":"Colorectal cancer survival gains and novel treatment regimens: a systematic review and analysis","volume":"1","author":"Jawed","year":"2015","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2021.05.022_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U","article-title":"Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis","volume":"14","author":"Sugarbaker","year":"1998","journal-title":"Semin Surg Oncol"},{"issue":"16","key":"10.1016\/j.ejso.2021.05.022_bib5","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2021.05.022_bib6","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2021.05.022_bib7","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyper- thermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of col- orectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2021.05.022_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.05.022_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejca.2015.09.017","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: a randomised trial","volume":"53","author":"Cashin","year":"2016","journal-title":"Eur J Canc"},{"issue":"5","key":"10.1016\/j.ejso.2021.05.022_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"6A","key":"10.1016\/j.ejso.2021.05.022_bib11","first-page":"747","article-title":"120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: S.I.T.I.L.O. multi- centric study","volume":"20","author":"Cavaliere","year":"2006","journal-title":"In\u00a0Vivo"},{"issue":"1","key":"10.1016\/j.ejso.2021.05.022_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2021.05.022_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00308632","article-title":"Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer","volume":"19","author":"Sugarbaker","year":"1995","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2021.05.022_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijsu.2015.08.078","article-title":"Impacts of low peritoneal cancer index on the survival outcomes of patient with peritoneal carcinomatosis of colorectal origin","volume":"23","author":"Huanga","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2021.05.022_bib15","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int J Canc"},{"key":"10.1016\/j.ejso.2021.05.022_bib16","first-page":"65","article-title":"Impacts of peritoneal cancer index on the survival outcomes of patients with colorectal peritoneal carcinomatosis","volume":"32","author":"Huang","year":"2016","journal-title":"Int J"},{"issue":"8","key":"10.1016\/j.ejso.2021.05.022_bib17","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","article-title":"Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal metastasis","volume":"22","author":"Simkens","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.022_bib18","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1245\/s10434-018-6823-9","article-title":"Postoperative complications independently predict cancer-related survival in peritoneal malignancies","volume":"25","author":"Haroon","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.022_bib19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s10147-019-01609-5","article-title":"High-Grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"25","author":"Wee-Shan Tan","year":"2020","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2021.05.022_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bjs5.50179","article-title":"Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy","volume":"3","author":"Hallam","year":"2019","journal-title":"BJS Open"},{"issue":"11","key":"10.1016\/j.ejso.2021.05.022_bib21","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","article-title":"Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin","volume":"40","author":"Elias","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.022_bib22","first-page":"20190018","volume":"4","author":"Spiliotis","year":"2019"},{"issue":"6","key":"10.1016\/j.ejso.2021.05.022_bib23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jso.23679","article-title":"Evaluation of a new staging classification and a Peritoneal Surface Disease Severity Score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination","volume":"110","author":"Esquivel","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2021.05.022_bib24","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1245\/s10434-014-3798-z","article-title":"The American society of peritoneal surface malignancies (ASPSM) multiinstitution evaluation of the peritoneal surface disease severity score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosis","volume":"21","author":"Esquivel","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.022_bib25","first-page":"29","article-title":"ESTRO\/ACROP IORT recommendations for intraoperative radiation therapy in primary locally advanced rectal cancer","volume":"25","author":"Calvo","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2021.05.022_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.suronc.2012.11.001","article-title":"Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications","volume":"22","author":"Mirnezami","year":"2013","journal-title":"Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2021.05.022_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/COC.0b013e318287bb8d","article-title":"Adjuvant chemoradiation plus intraoperative radiotherapy versus adjuvant chemoradiation alone in patients with locally advanced rectal cancer","volume":"38","author":"Zhang","year":"2015","journal-title":"Am J Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321004984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321004984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:40:48Z","timestamp":1760060448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321004984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0748798321004984"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.05.022","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of \u201ccritical lesions\u201d on outcomes following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}